The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 first-in-human, dose-escalation and -expansion study of RYZ401, a novel radiopharmaceutical therapy (RPT) labeled with actinium-225 (225Ac), in patients with neuroendocrine tumors (NETs) and other solid tumors expressing somatostatin receptors (SSTRs).
 
Heloisa Soares
Honoraria - TM Isotope Technologies Munich SE
Consulting or Advisory Role - Bristol-Myers Squibb; Curium Pharma; Exelixis; Ipsen; Novartis
(OPTIONAL) Uncompensated Relationships - Healing NET Foundation; NCCN; North American Neuroendocrine Tumor Society
 
Rebecca Wong
Honoraria - Elekta; Novartis
Research Funding - Bruce Power (Inst); Celgene/Bristol-Myers Squibb (Inst); Novartis (Inst); POINT Biopharma (Inst); Precirix (Inst); RayzeBio (Inst)
 
Lowell Anthony
Stock and Other Ownership Interests - Doximity
Honoraria - Boehringer Ingelheim; Curium Pharma; TerSera
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Camurus (Inst); Crinetics Pharmaceuticals (Inst); RayzeBio (Inst)
 
Petr Kavan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical
 
Robert Ramirez
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; EMD Serono; Ipsen; Novartis
Speakers' Bureau - Advanced Accelerator Applications; AstraZeneca; Genentech/Roche; Guardant Health; Ipsen; Merck
Research Funding - AADi (Inst); Merck (Inst)
 
Martin Allen-Auerbach
No Relationships to Disclose
 
Vikas Prasad
Consulting or Advisory Role - Bayer HealthCare Pharmacuticals; Cellectar; Curium Pharma; Lantheus Medical Imaging; Lilly; Telix Pharmaceuticals
Speakers' Bureau - Curium Pharma
Travel, Accommodations, Expenses - RayzeBio; Telix Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - ECOG-ACRIN; ENETS; ESMO; ICPO Foundation; SNMMI
 
Matthew Reilley
Consulting or Advisory Role - Pfizer; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Cardiff Oncology (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst); Takeda (Inst); Xencor (Inst); ZielBio (Inst)
 
Medhat Osman
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Point BioPharma, Novartis, Fusion Pharmaceuticals, Clarity, Curium, Perspective Therapeutics, RayzeBio
 
Mohamad Sonbol
Honoraria - Novartis
Consulting or Advisory Role - Bayer (Inst); Boehringer Ingelheim (Inst)
Research Funding - Lilly (Inst); Taiho Oncology (Inst)
 
Thorvardur Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Biomea Fusion; Boehringer Ingelheim; Camurus (Inst); Crinetics Pharmaceuticals (Inst); Curium Pharma; Exelixis; Ipsen (Inst); ITM Isotope Technologies Munich (Inst); Perspective Therapeutics (Inst); Tersera; Viewpoint Molecular Targeting (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst); Perspective Therapeutics (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
(OPTIONAL) Uncompensated Relationships - North American Neuroendocrine Tumor Society
 
Jason Starr
Consulting or Advisory Role - Exelixis
Research Funding - Amgen (Inst); Aminex (Inst); Arcus Biosciences (Inst); Camurus (Inst); RayzeBio (Inst); Viewpoint Molecular Targeting (Inst)
 
Dipen Patel
No Relationships to Disclose
 
Denis Ferreira
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Roberta Susnow
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Xuemei Wang
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Simron Singh
Employment - Sanofi (I)
Honoraria - Advanced Accelerator Applications/Novartis; IPSEN
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Camurus; IPSEN; ITM Isotope Technologies Munich; McKesson; Sanofi